Danielle Lehman September 16, 2018 Update on RG6042 (formerly known as IONIS-HTTRx) Huntington’s disease global development programme: Two clinical studies to begin by end of 2018 Danielle Lehman September 16, 2018 Click here to read the letter from Genentech, a member of the Roche group.